2025-08-08 - Analysis Report
Okay, here's a report summarizing the provided data for Hims & Hers Health Inc (HIMS), focusing on key metrics and providing a concise analysis.

## HIMS (Hims & Hers Health Inc) Report

Hims & Hers Health Inc is a telehealth company that offers personalized treatments for various conditions, primarily focusing on men's and women's health.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 179.73%
*   **VOO (S&P 500) Cumulative Return:** 67.96%
*   **Relative Divergence:**
    *   Current Divergence: 180.8
    *   Min: -88.4, Max: 288.9
    *   Current Relative Divergence: 71.3

**Analysis:** HIMS has significantly outperformed the S&P 500. The relative divergence of 71.3 indicates that HIMS's outperformance, while substantial, is positioned in the upper range of its historical divergence from the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2019-2021  | -46.0%  | 51.0%   | -85.0%  | 0.1    | 1.5    |
| 2020-2022  | -15.0%  | 72.1%   | -21.0%  | 0.0    | 1.4    |
| 2021-2023  | -51.0%  | 72.1%   | -71.0%  | -0.2   | 2.0    |
| 2022-2024  | 127.0%  | 78.4%   | 100.0%  | -0.3   | 5.5    |
| 2023-2025  | 175.0%  | 78.4%   | 127.0%  | -0.2   | 11.5   |

**Analysis:**

*   **CAGR:** Volatile, with significant negative returns in earlier periods and strong positive returns more recently.
*   **MDD:** High Maximum Drawdown values indicate substantial risk and volatility.
*   **Alpha:** Varies significantly, indicating periods of underperformance and outperformance relative to the market.  Recent periods show strong positive alpha.
*   **Beta:** Generally high and increasing, suggesting the stock is more sensitive to market movements than the S&P 500 and implying increasing volatility.

### 2. Recent Stock Price Movement

*   **Current Price:** 51.05
*   **Last Market Data:** price': 51.05, 'previousClose': 51.13, 'change': -0.16} (Slight decrease from previous close)
*   **5-Day Moving Average:** 56.72
*   **20-Day Moving Average:** 55.37
*   **60-Day Moving Average:** 54.64

**Analysis:** The current price is below all three moving averages (5, 20, and 60 day), suggesting a potential short-term downward trend. However, the moving averages are relatively close, indicating consolidation or a period of uncertainty.  The slight decrease from the previous close is not a significant event on its own.

### 3. Market Risk and Expected Return

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 50.85 (Neutral)
*   **PPO:** -1.26 (Slightly bearish momentum)
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings
*   **Recent (20-day) Relative Divergence Change:** 7.7 (+): Short-term increase
*   **Expected Return:** -8.7% (Long-term underperformance vs. S&P 500 if investing now)

**Analysis:** The MRI indicates low market risk. The RSI is neutral, suggesting neither overbought nor oversold conditions. The negative PPO indicates slightly bearish momentum. Hybrid signal suggests selling 0.1% of holdings to cash 70%. The recent increase in relative divergence is a positive signal.  However, the negative expected return is concerning and suggests that, based on current valuations, long-term investments may underperform the S&P 500.

### 4. Recent News & Significant Events

*   **2025-08-05:** Major business developments, regulatory changes, or market events.
*   **2025-08-04:** Analysts discussing recent performance and outlook.
*   **2025-08-06:** Notable stock volatility.
*   **2025-08-07:** Market experts highlighting both risks and opportunities.

**Analysis:** Recent news suggests the company is experiencing significant activity, including analyst interest, volatility, and potentially major developments. Investors should closely monitor these news events.

### 5. Recent Earnings Analysis:

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-08-04 | 0.19 | 0.54 B$   |
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2025-08-04 | 0.06 | 0.32 B$   |

**Analysis:**  The EPS and revenue figures show a general upward trend over the past few quarters, although there are fluctuations. The revenue has been increasing steadily and EPS has fluctuated due to business development, regulatory changes, or market events.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $0.54B   | 76.39%        |
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |
| 2024-06-30   | $0.32B   | 81.30%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE       |
|--------------|----------|-----------|
| 2025-06-30   | $0.56B   | 7.55%     |
| 2025-03-31   | $0.55B   | 9.01%     |
| 2024-12-31   | $0.48B   | 5.46%     |
| 2024-09-30   | $0.44B   | 17.18%    |
| 2024-06-30   | $0.36B   | 3.67%     |

**Analysis:** Revenue is generally increasing, indicating strong sales growth.  Profit margins are consistently high, suggesting effective cost management.  Equity is growing, indicating financial strength. ROE is fluctuating but generally healthy, indicating good returns on equity.

### 7. Overall Summary

HIMS has significantly outperformed the S&P 500, but recent data presents a mixed picture. While revenue, profit margins, and equity are growing, and market risk is low, the stock price is below moving averages, PPO indicates slightly bearish momentum, and the expected return is negative. This suggests that, despite strong fundamentals, the stock may be currently overvalued or facing short-term headwinds.

**Recommendation:** Investors should carefully weigh the positive long-term growth potential against the short-term risks and potential for underperformance. Monitoring upcoming news events and analyst reports will be crucial for making informed decisions. Hybrid signal suggests selling 0.1% of holdings to cash 70%.
